Toxoplasma gondii infection in cancer patients: Prevalence, risk factors, genotypes and association with clinical diagnosis

Cancer Letters

Volumn 359, Issue 2, 2015, Pages 307-313

  Cong, Wei ^a,b   Liu, Guo Hua ^a   Meng, Qing Feng ^c   Dong, Wei ^d   Qin, Si Yuan ^a,b   Zhang, Fu Kai ^a   Zhang, Xiang Yan ^e   Wang, Xiang Yang ^f   Qian, Ai Dong ^b   Zhu, Xing Quan ^a,b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b JILIN AGRICULTURAL UNIVERSITY   (China)

^c Jilin Entry Exit Inspection and Quarantine Bureau   (China)

^d Weihaiwei People's Hospital   (China)

^e QINGDAO UNIVERSITY   (China)

^f Weihai   (China)

Author keywords

Cancer patients; Genotype; Prevalence; Risk factors; Toxoplasma gondii

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN G; PROTOZOON ANTIBODY;

ADULT; AGED; ARTICLE; B1 GENE; BRAIN CANCER; CANCER PATIENT; CASE CONTROL STUDY; CHINA; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; FOOD INTAKE; GENE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RAW MEAT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEROPREVALENCE; SOIL; TOXOPLASMOSIS; UTERINE CERVIX CANCER; BLOOD; BRAIN NEOPLASMS; ENDOMETRIAL NEOPLASMS; GENETICS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LUNG NEOPLASMS; MIDDLE AGED; PARASITOLOGY; TOXOPLASMA; UTERINE CERVICAL NEOPLASMS;

TOXOPLASMA GONDII;

ADULT; AGED; ANTIBODIES, PROTOZOAN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHINA; ENDOMETRIAL NEOPLASMS; FEMALE; GENES, PROTOZOAN; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TOXOPLASMA; TOXOPLASMOSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84923072235     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.01.036     Document Type: Article

References (41)

1. Cannon G., Gupta P., Gomes F., Kerner J., Parra W., Weiderpass E., et al. Prevention of cancer and non-communicable diseases. Asian Pac. J. Cancer Prev 2012, 13:3-11.
2. WHO - World Health Organization Cancer. Fact. Sheet 2011, 297.
3. International Agency for Research on Cancer (IARC) Working Group, Agents Classified by the IARC Monographs 2008, IARC, Lyon (France).
4. Ahmed H.G. Awareness survey on knowledge of microbial infectious causes of cancer in northern state of Sudan. Asian Pac. J. Cancer Prev 2012, 13:5497-5500.
5. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., Benbrahim-Tallaa L., et al. WHO international agency for research on cancer monograph working group. a review of human carcinogens - part b: biological agents. Lancet Oncol 2009, 10:321-322.
6. Zur Hausen H. Streptococcus bovis: causal or incidental involvement in cancer of the colon?. Int. J. Cancer 2006, 119:11-12.
7. Dubey J.P. Toxoplasmosis of Animals and Humans 2010, p. 313. CRC Press, Boca Raton, Florida. second ed.
8. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
9. Shaw M.H., Reimer T., Sánchez-Valdepeñas C., Warner N., Kim Y.G., Fresno M., et al. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat. Immunol 2009, 10:1267-1274.
10. Schlüter D., Kwok L.Y., Lütjen S., Soltek S., Hoffmann S., Körner H., et al. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol 2003, 170:6172-6182.
11. Michel G., Thuret I., Chambost H., Scheiner C., Mary C., Perrimond H. Lung toxoplasmosis after HLA mismatched bone marrow transplantation. Bone Marrow Transplant 1994, 14:455-457.
12. Ryan P., Hurley S.F., Johnson A.M., Salzberg M., Lee M.W., North J.B., et al. Tumours of the brain and presence of antibodies to Toxoplasma gondii. Int. J. Epidemiol 1993, 22:412-419.
13. Dawis M.A., Bottone E.J., Vlachos A., Burroughs M.H. Unsuspected Toxoplasma gondii empyema in a bone marrow transplant recipient. Clin. Infect. Dis 2002, 34:7-9.
14. Lehmann T., Marcet P.L., Graham D.H., Dahl E.R., Dubey J.P. Globalization and the population structure of Toxoplasma gondii. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11423-11428.
15. Su C., Khan A., Zhou P., Majumdar D., Ajzenberg D., Dardé M.L., et al. Globally diverse Toxoplasma gondii isolates comprise six major clades originating from a small number of distinct ancestral lineages. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:5844-5849.
16. Dardé M.L., Bouteille B., Pestre-Alexandre M. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol 1992, 78:786-794.
17. Howe D.K., Sibley L.D. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J. Infect. Dis 1995, 172:1561-1566.
18. Ajzenberg D., Bañuls A.L., Tibayrenc M., Dardé M.L. Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism structured into two main clonal groups. Int. J. Parasitol 2002, 32:27-38.
19. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82-85.
20. Fux B., Rodrigues C.V., Portela R.W., Silva N.M., Su C., Sibley L.D., et al. Role of cytokines and major histocompatibility complex restriction in mouse resistance to infection with a natural recombinant strain (type I-III) of Toxoplasma gondii. Infect. Immun 2003, 71:6392-6401.
21. Peyron F., Lobry J.R., Musset K., Ferrandiz J., Gomez-Marin J.E., Petersen E., et al. Serotyping of Toxoplasma gondii in chronically infected pregnant women: predominance of type II in Europe and type I and III in Colombia (South America). Microbes Infect 2006, 8:2333-2340.
22. Yuan Z., Gao S., Liu Q., Xia X., Liu X., Liu B., et al. Toxoplasma gondii antibodies in cancer patients. Cancer Lett 2007, 254:71-74.
23. Hill D.E., Chirukandoth S., Dubey J.P., Lunney J.K., Gamble H.R. Comparison of detection methods for Toxoplasma gondii in naturally and experimentally infected swine. Vet. Parasitol 2006, 141:9-17.
24. Su C., Shwab E.K., Zhou P., Zhu X.Q., Dubey J.P. Moving towards an integrated approach to molecular detection and identification of Toxoplasma gondii. Parasitology 2010, 137:1-11.
25. Cong W., Huang S.Y., Zhou D.H., Zhang X.X., Zhang N.Z., Zhao Q., et al. Prevalence and genetic characterization of Toxoplasma gondii in house sparrows (Passer domesticus) in Lanzhou, China. Korean J. Parasitol 2013, 51:363-367.
26. Cong W., Meng Q.F., Song H.Q., Zhou D.H., Huang S.Y., Qian A.D., et al. Seroprevalence and genetic characterization of Toxoplasma gondii in three species of pet birds in China. Parasit. Vectors 2014, 7:152.
27. Benamrouz S., Conseil V., Creusy C., Calderon E., Dei-Cas E., Certad G. Parasites and malignancies, a review, with emphasis on digestive cancer induced by Cryptosporidium parvum (Alveolata: Apicomplexa). Parasite 2012, 19:101-115.
28. Yazar S., Yaman O., Eser B., Altuntas F., Kurnaz F., Sahin I. Investigation of anti-Toxoplasma gondii antibodies in patients with neoplasia. J. Med. Microbiol 2004, 53:1183-1186.
29. Długońska H., Grzybowski M.M. Functional exhaustion of T lymphocytes in chronic toxoplasmosis. Ann. Parasitol 2013, 59:109-112.
30. Bhadra R., Khan I.A. Redefining chronic toxoplasmosis - a T cell exhaustion perspective. PLoS Pathog 2012, 8:e1002903.
31. Nowakowska D., Wujcicka W., Sobala W., Spiewak E., Gaj Z., Wilczyński J. Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012. Epidemiol. Infect 2014, 142:656-661.
32. Falusi O., French A.L., Seaberg E.C., Tien P.C., Watts D.H., Minkoff H., et al. Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection. Clin. Infect. Dis 2002, 35:1414-1417.
33. Jones J.L., Dargelas V., Roberts J., Press C., Remington J.S., Montoya J.G. Risk factors for Toxoplasma gondii infection in the United States. Clin. Infect. Dis 2009, 49:878-884.
34. Torrey E.F., Yolken R.H. Toxoplasma oocysts as a public health problem. Trends Parasitol 2013, 29:380-384.
35. Du F., Feng H.L., Nie H., Tu P., Zhang Q.L., Hu M., et al. Survey on the contamination of Toxoplasma gondii oocysts in the soil of public parks of Wuhan, China. Vet. Parasitol 2012, 184:141-146.
36. Velmurugan G.V., Dubey J.P., Su C. Genotyping studies of Toxoplasma gondii isolates from Africa revealed that the archetypal clonal lineages predominate as in North America and Europe. Vet. Parasitol 2008, 155:314-318.
37. Ajzenberg D. Type I strains in human toxoplasmosis: myth or reality?. Future. Microbiol 2010, 5:841-843.
38. Wang L., Chen H., Liu D., Huo X., Gao J., Song X., et al. Genotypes and mouse virulence of Toxoplasma gondii isolates from animals and humans in China. PLoS ONE 2013, 8:e53483.
39. Zhou P., Nie H., Zhang L.X., Wang H.Y., Yin C.C., Su C., et al. Genetic characterization of Toxoplasma gondii isolates from pigs in China. J. Parasitol 2010, 96:1027-1029.
40. Tian Y.M., Huang S.Y., Miao Q., Jiang H.H., Yang J.F., Su C., et al. Genetic characterization of Toxoplasma gondii from cats in Yunnan Province, Southwestern China. Parasit. Vectors 2014, 7:178.
41. Liu Q., Cao L., Zhu X.Q. Major emerging and re-emerging zoonoses in China: a matter of global health and socio-economic development for 1.3 billion. Int. J. Infect. Dis 2014, 25:e65-e72.